Alpine Immune Sciences Inc
ALPN
Market Cap$0
Close$
$37.58
42.2% downside
Current Fair Value
42.2% downsideOvervalued by 42.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-296,006,000.00 |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.68 |
| Beta | 0.0 |
| Outstanding Shares | 68,597,527 |
| Avg 30 Day Volume | 0 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0.0 |
|---|---|
| PEG | 0.0 |
| Price to Sales | - |
| Price to Book Ratio | 16.24 |
| Enterprise Value to Revenue | -5.24 |
| Enterprise Value to EBIT | 5.76 |
| Enterprise Value to Net Income | 8 |
| Total Debt to Enterprise | -0.03 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Alpine Immune Sciences Inc
CEO: Mitchell Gold